Is oral combination therapy with a proton-pump inhibitor and H2 receptor antagonist effective as initial treatment?
Masahiko
M
Inamori
Keiko
K
Akimoto
Tomoyuki
T
Akiyama
Koji
K
Fujita
Hirokazu
H
Takahashi
Masato
M
Yoneda
Yasunobu
Y
Abe
Hiroyuki
H
Kirikoshi
Kensuke
K
Kubota
Satoru
S
Saito
Norio
N
Ueno
Atsushi
A
Nakajima
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage*; D000081:Acetamides / Q000008:administration & dosage*; D000284:Administration, Oral; D000328:Adult; D004359:Drug Therapy, Combination; D006635:Histamine H2 Antagonists / Q000008:administration & dosage*; D006801:Humans; D064747:Lansoprazole; D008297:Male; D010880:Piperidines / Q000008:administration & dosage*; D054328:Proton Pump Inhibitors; D011725:Pyridines / Q000008:administration & dosage*
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000081:Acetamides; D006635:Histamine H2 Antagonists; D010880:Piperidines; D054328:Proton Pump Inhibitors; D011725:Pyridines; D064747:Lansoprazole; C076948:lafutidine